#United States #New York City #AbbVie #Lymphoma Research #Peter Martin

The Lymphoma Research Foundation's 2026 Annual Gala

On November 13, 2026, the Lymphoma Research Foundation will host its prestigious Annual Gala at the iconic Ziegfeld Ballroom in New York City. This event, a cornerstone for fundraising efforts, marks a vital occasion for recognizing pivotal contributions in lymphoma research, patient support, and philanthropy. The gala will celebrate Dr. Peter Martin, AbbVie, and the Werner Family as notable honorees, each making significant strides in their respective fields.

A Commitment to Research and Advocacy

This year's gala highlights the unwavering dedication of individuals and organizations working tirelessly to improve the lives of those affected by lymphoma and chronic lymphocytic leukemia (CLL). Meghan Gutierrez, the Foundation's Chief Executive Officer, stated, “The progress we have made for people affected by lymphoma and CLL is because of the extraordinary commitment of researchers, clinicians, patients, families, and partners who believe in our mission.” The gala serves not only as a platform to honor these contributions but also as an essential source of funding, having raised over $1.4 million last year alone to further the Foundation's mission of eradicating lymphoma.

Honorees of 2026

Dr. Peter Martin (Distinguished Leadership Award)

Dr. Peter Martin, a highly regarded hematologist-oncologist at NYU Langone Health, will be recognized with the Distinguished Leadership Award. His groundbreaking work in lymphoma care and research has substantially advanced treatment approaches and outcomes for patients. Dr. Martin's commitment to research reflects a profound dedication to enhancing the lives of those facing lymphoma, making him a deserving recipient of this honor.

The Werner Family (Legacy Award)

The Werner Family will be awarded the Legacy Award, acknowledging their vital contributions to lymphoma research following the diagnosis of Michael Werner. Their devoted philanthropy demonstrates a lasting commitment to the lymphoma community, inspiring many other families to support vital research efforts.

AbbVie (Corporate Leadership Award)

AbbVie will receive the Corporate Leadership Award, recognizing its exceptional commitment to advancing lymphoma research. The company's sustained investments in scientific initiatives and patient education programs have made a profound impact on the lymphoma community. Svetlana Kobina, AbbVie’s Vice President of Global Media Affairs for Oncology, expressed gratitude for the recognition, stating, “Receiving this acknowledgment from the Lymphoma Research Foundation is a tremendous honor. It reflects our commitment to advancing lymphoma research and developing innovative therapies for patients living with blood cancer.”

The Importance of the Gala

This Annual Gala is more than just a celebration; it embodies unity and collaboration among various stakeholders dedicated to fighting lymphoma. It offers a unique opportunity to spotlight individuals and organizations that significantly uplift the lymphoma community through commitment and innovative research. The funds raised during the event will enable the Foundation to invest in promising research initiatives and provide essential support services for individuals impacted by lymphoma.

Event Details

• - What: Lymphoma Research Foundation's 2026 Annual Gala
• - When: Friday, November 13, 2026
• - Where: Ziegfeld Ballroom, 141 W 54th Street, New York, NY 10019

About the Lymphoma Research Foundation

As the largest nonprofit organization focused exclusively on innovative lymphoma research, the Lymphoma Research Foundation plays a critical role in supporting patients and their families. Through various educational programs, outreach initiatives, and patient services, the Foundation seeks to enhance the quality of life for those affected by lymphoma. For detailed information about the Foundation's activities and research highlights, please visit lymphoma.org.

Connect with us on social media platforms like Facebook, X (formerly Twitter), YouTube, Instagram, and LinkedIn to stay updated on the latest in lymphoma research and advocacy efforts.